Aortic Repair Devices – Market Insights – Japan

The Japanese aortic repair device market will grow at a modest rate, which in turn is attributed to shift towards premium-priced endovascular procedures, large and expanding patient pool of aortic aneurysms, availability of new clinical data to support the adoption of existing products and launch of new aortic repair devices in Japan during the forecast period. However, market revenues growth will be limited by eroding ASPs due to biennial reimbursement cuts by the MHLW, particularly in the aortic surgical grafts market and to some extent by unavailability of aortic stent grafts brands for certain indications.

Medtech 360 Report provides comprehensive data and analysis on the state of the market for aortic repair devices in Japan from 2019 through 2032.

A number of innovative devices were launched in recent years in the lucrative aortic stent graft device market.

How have the market dynamics changed with new launches?

What competitive strategies competitors are deploying to gain share in this market?

What factors are limiting aortic stent graft market revenue growth?

Novel devices are expected to gain approval in the Japanese aortic repair device market.

What recent developments have occurred in the aortic stent grafts segment?

Which devices are in the developmental pipeline?

When are the devices expected to gain approval in the Japanese aortic repair device market?

What impact will major clinical trials being conducted have on the market?

What factors are influencing the adoption of existing products in Japanese aortic repair device market?

Aortic repair can be performed using endovascular, surgical, or hybrid procedures.

Which methods are preferred for which indications?

To what extent are hybrid aortic repair procedures being performed for the aortic arch and thoracoabdominal indications in Japan?

How will the launch of new custom-made hybrid stent grafts affect the market?

The penetration of endovascular treatment methods for aortic repair is growing.

What are the main drivers and limiters of growth in the Japanese endovascular aortic repair device market?

Which indication has seen the highest penetration of endovascular treatments?

For which indications will uptake of endovascular aortic repair procedures be limited and why?

Biennial MHLW reimbursement cuts will continue to negatively affect the Japanese aortic repair device market.

Which device segments has been most affected by the MHLW reimbursement cuts, and to what extent will the different device markets be impacted?

What other factors will affect ASP trends?